Fig. 1

Flowchart of the 1282 consecutive patients treated with ICS/LABA between April 2021 and March 2023. Of these patients, 118 who presented with uncontrolled asthma switched treatment. Moreover, 42 patients taking high-dose ICS/LABA switched to high-dose ICS/LAMA/LABA